SPCC74.04 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC74.04Uncharacterized amino-acid permease C74.04 antibody
Target Names
SPCC74.04
Uniprot No.

Target Background

Database Links
Protein Families
Amino acid-polyamine-organocation (APC) superfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is SPCC74.04 and what is its significance in research?

SPCC74.04 is a protein found in Schizosaccharomyces pombe (fission yeast), a model organism widely used in molecular and cellular biology research. This protein is studied primarily in the context of fundamental eukaryotic cellular processes. The anti-SPCC74.04 antibody is a rabbit-derived polyclonal antibody that recognizes this protein . This antibody serves as an important tool for researchers investigating protein expression, localization, and function in S. pombe, particularly in studies examining conserved cellular mechanisms that may have relevance to human biology.

How does the polyclonal nature of anti-SPCC74.04 antibody affect experimental design?

The polyclonal nature of the anti-SPCC74.04 antibody means it contains a heterogeneous mixture of antibodies that recognize different epitopes on the SPCC74.04 protein . This characteristic offers both advantages and challenges for experimental design:

Advantages:

  • Enhanced signal detection due to binding at multiple epitopes

  • Greater tolerance to minor protein denaturation or conformational changes

  • Potentially higher sensitivity for detecting low-abundance targets

Design considerations:

  • Higher potential for cross-reactivity requiring thorough validation controls

  • Batch-to-batch variation necessitating consistent validation

  • May require more extensive blocking procedures to minimize background

When designing experiments using this antibody, researchers should implement epitope mapping and cross-reactivity testing to fully characterize the binding profile.

What experimental variables must be defined when designing studies with anti-SPCC74.04 antibody?

When designing experiments with anti-SPCC74.04 antibody, researchers must clearly define several types of variables:

Independent variables: These are the parameters you deliberately manipulate, such as antibody concentration, incubation time, temperature, or treatment conditions applied to your samples .

Dependent variables: These are the measurements that reflect your experimental outcomes, such as signal intensity, percentage of positive cells, subcellular localization patterns, or protein expression levels .

Control variables: These factors must be kept constant across experimental conditions and may include buffer composition, blocking reagents, and sample preparation methods.

Confounding variables: These are factors that might inadvertently affect your results, such as cell passage number, sample storage conditions, or experimenter technique variations .

A robust experimental design will account for all these variable types while incorporating appropriate controls and sufficient replication to ensure statistical validity.

What controls are essential when working with anti-SPCC74.04 antibody?

Control TypePurposeImplementation
Negative ControlsIdentify non-specific bindingOmit primary antibody; use preimmune serum
Specificity ControlsVerify antibody specificityUse blocking peptide; SPCC74.04 knockout/knockdown samples
Positive ControlsConfirm assay functionalityUse samples with known SPCC74.04 expression
Isotype ControlsAssess background from antibody classUse non-specific rabbit IgG at equivalent concentration
Technical ControlsAccount for technical variationInclude replicate samples; standard curves

For SPCC74.04 specifically, using wild-type S. pombe strains alongside SPCC74.04 deletion mutants provides the strongest validation of antibody specificity. Additionally, comparative analysis with tagged SPCC74.04 constructs can further confirm antibody target recognition.

What is the recommended protocol for immunocytochemistry using anti-SPCC74.04 antibody?

Based on established immunocytochemistry protocols for yeast proteins and general antibody applications, the following methodology is recommended:

  • Fix cells with 4% paraformaldehyde in PBS for 10 minutes at room temperature (avoid organic solvents that might dissolve membrane proteins)

  • Wash three times with PBS, 5 minutes each

  • Permeabilize cells with 0.1% Triton X-100 for 5 minutes (optimize for SPCC74.04 localization)

  • Block non-specific binding with 5% FCS in PBS for 30 minutes at room temperature

  • Incubate with anti-SPCC74.04 primary antibody (10-20 μg/mL) for 1 hour at 37°C

  • Wash three times with PBS

  • Incubate with fluorescently-labeled secondary antibody (anti-rabbit IgG) for 1 hour at 37°C

  • Wash three times with PBS

  • Counterstain nuclei with DAPI if desired

  • Mount using appropriate medium and examine by fluorescence microscopy

Critical notes:

  • Do not allow preparations to dry during the staining procedure

  • Optimize antibody concentrations for your specific application

  • For S. pombe, cell wall digestion with zymolyase may be necessary before fixation

How should western blotting be optimized for SPCC74.04 detection?

For optimal western blotting results with anti-SPCC74.04 antibody:

  • Sample preparation:

    • Lyse S. pombe cells using glass bead disruption in appropriate buffer

    • Include protease inhibitors to prevent degradation

    • Denature samples at 95°C for 5 minutes in sample buffer

  • Gel electrophoresis:

    • Use 10-12% SDS-PAGE gels based on the predicted molecular weight of SPCC74.04

    • Include molecular weight markers and positive control samples

  • Transfer optimization:

    • Use PVDF membranes for optimal protein binding

    • Transfer at 100V for 1 hour or 30V overnight at 4°C

  • Blocking and antibody incubation:

    • Block with 5% non-fat dry milk or BSA in TBST for 1 hour

    • Incubate with anti-SPCC74.04 antibody (1:500-1:2000 dilution, optimized)

    • Wash thoroughly with TBST (3-5 times, 5 minutes each)

    • Incubate with HRP-conjugated secondary antibody

  • Detection and analysis:

    • Use enhanced chemiluminescence (ECL) detection system

    • Optimize exposure times to avoid signal saturation

    • Quantify using appropriate software with normalization to loading controls

How can non-specific binding issues with anti-SPCC74.04 antibody be addressed?

Non-specific binding is a common challenge when working with polyclonal antibodies. For anti-SPCC74.04 antibody, consider these systematic approaches:

  • Increase blocking stringency:

    • Extend blocking time to 2 hours or overnight at 4°C

    • Test alternative blocking agents (BSA, casein, fish gelatin)

    • Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

  • Optimize antibody conditions:

    • Titrate antibody concentration to find optimal signal-to-noise ratio

    • Increase wash duration and number of washes

    • Perform antibody incubation at 4°C overnight instead of 37°C

  • Sample-specific strategies:

    • Pre-absorb antibody with wild-type yeast lysate lacking SPCC74.04

    • Use higher dilutions of primary antibody

    • Add 0.1-0.5M NaCl to washing buffer to disrupt low-affinity interactions

  • Cross-species considerations:

    • If using in non-S. pombe systems, conduct thorough cross-reactivity testing

    • Consider epitope-specific purification of the polyclonal preparation

When troubleshooting, change only one parameter at a time and document results systematically to identify optimal conditions.

What approaches can validate the specificity of anti-SPCC74.04 antibody results?

Validation ApproachMethodologyInterpretation
Genetic ValidationUse SPCC74.04 knockout/knockdown strainsSignal should be absent or reduced in mutants
Peptide CompetitionPre-incubate antibody with purified SPCC74.04 peptideSpecific signals should be blocked
Orthogonal DetectionCompare with GFP-tagged SPCC74.04 detectionPatterns should overlap substantially
Multiple AntibodiesTest different antibodies against SPCC74.04Similar patterns indicate specificity
Mass SpectrometryAnalyze immunoprecipitated materialShould identify SPCC74.04 and known interactors

For comprehensive validation, combining at least two of these approaches is recommended. The gold standard remains genetic validation using SPCC74.04 deletion strains, which should show complete absence of specific signal.

How can anti-SPCC74.04 antibody be effectively used in protein-protein interaction studies?

For investigating SPCC74.04 protein interactions, consider these methodological approaches:

  • Co-immunoprecipitation (Co-IP):

    • Use anti-SPCC74.04 antibody conjugated to protein A/G beads

    • Perform under native conditions to preserve protein-protein interactions

    • Analyze precipitated complexes by western blot or mass spectrometry

    • Include stringent controls (IgG control, reversed Co-IP)

  • Proximity Ligation Assay (PLA):

    • Combine anti-SPCC74.04 with antibodies against suspected interaction partners

    • PLA signal indicates proximity of <40nm between proteins

    • Quantify interaction signals per cell to assess interaction frequency

  • Immunofluorescence co-localization:

    • Perform dual labeling with anti-SPCC74.04 and partner protein antibodies

    • Analyze co-localization coefficients (Pearson's, Manders')

    • Use super-resolution microscopy for improved spatial resolution

  • FRET-based approaches:

    • Combine antibody-based detection with fluorescence resonance energy transfer

    • Measures direct protein interactions at nanometer scale

    • Can be analyzed by microscopy or flow cytometry

When reporting interaction data, quantitative analyses should be performed across multiple cells and experiments to establish statistical significance of observed interactions.

What considerations are important when designing multi-parameter flow cytometry experiments with anti-SPCC74.04 antibody?

For complex flow cytometry experiments incorporating anti-SPCC74.04 antibody:

  • Panel design considerations:

    • Select fluorophores with minimal spectral overlap

    • Place anti-SPCC74.04 antibody on brightest fluorophore if target expression is low

    • Include compensation controls for each fluorophore

  • Sample preparation for yeast cells:

    • Optimize cell wall digestion protocols (zymolyase treatment)

    • Ensure complete permeabilization for intracellular targets

    • Maintain cell viability during processing if analyzing live cells

  • Controls specific to SPCC74.04 detection:

    • Fluorescence-minus-one (FMO) controls to set proper gates

    • SPCC74.04 deletion strains as negative controls

    • Titration of antibody to determine optimal concentration

  • Data analysis approaches:

    • Use dimensionality reduction techniques (tSNE, UMAP) for complex datasets

    • Apply unsupervised clustering to identify cell populations

    • Correlate SPCC74.04 expression with other cellular parameters

  • Validation strategies:

    • Confirm flow cytometry results with microscopy

    • Verify expression patterns with western blotting

    • Perform biological replicates to ensure reproducibility

This multi-parameter approach allows for correlation of SPCC74.04 expression or modification with cell cycle stage, stress responses, or other cellular states.

How can anti-SPCC74.04 antibody be integrated into single-cell analytical techniques?

Emerging single-cell techniques offer new opportunities for SPCC74.04 research:

  • Single-cell western blotting:

    • Isolate individual yeast cells in microwell arrays

    • Lyse cells in situ and separate proteins by size

    • Probe with anti-SPCC74.04 antibody

    • Quantify expression variability between individual cells

  • Mass cytometry (CyTOF):

    • Label anti-SPCC74.04 antibody with rare earth metals

    • Combine with up to 40 additional cellular markers

    • Analyze protein expression in thousands of single cells

    • Requires metal-conjugated antibodies or metal-tag secondary antibodies

  • Imaging mass cytometry:

    • Combine spatial resolution with high-parameter analysis

    • Visualize SPCC74.04 in tissue context with subcellular resolution

    • Correlate with dozens of additional protein markers

  • Spatial transcriptomics correlation:

    • Combine anti-SPCC74.04 immunofluorescence with spatial transcriptomics

    • Correlate protein localization with gene expression patterns

    • Integrate multi-omics data at single-cell resolution

These techniques enable researchers to move beyond population averages and examine cell-to-cell variability in SPCC74.04 expression, localization, and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.